Three consecutive gold medals for urology trainees
A doctor at Imperial College Healthcare NHS Trust has been awarded for exceptional performance in her recent surgical exams by the Royal College of Surgeons.
Miss Hazel Ecclestone, a specialist registrar at the Trust, was awarded the coveted Gold Medal after performing exceptionally well in the recent Fellowship of The Royal College of Surgeons Urology examinations (FRCS Urol).
This is the third time in a row that the Gold Medal has been awarded to a trainee from the Trust’s Urological Specialist Surgical Training Programme. The previous winners were Ms Tina Rashid and Mr Erik Mayer, who both joined the Trust as consultants after they completed their training.
Consultant and specialty lead for urology Mr David Hrouda said: “This prestigious prize is not awarded at every sitting of the exam, but reserved for outstanding all-round performance and was well-deserved by these surgeons. Everyone in the department is very proud of them.
“These exceptional results in national exit examinations reflect the high quality of trainees attracted to the Trust’s training programme as well as the high quality of urology postgraduate teaching and training at the Trust and in our partner hospitals.”
The Trust’s exemplary training programme has implemented innovative hands-on teaching methods, making use of simulators and cutting-edge technology. Trainees also experience paired-learning which spans professional groups to provide a bigger picture understanding of the surgical department and produce consultants fit for the modern NHS.
Mr Mathias Winkler, specialty training programme director for North London said: “I am thrilled that these individuals have been recognised for all their hard work and expertise. These awards also reflect the calibre of the training programme we offer here at Imperial Lead Provider, where we are continually striving to be the best.”
This third consecutive trainee award comes just after the Trust’s urological surgery team out-performed twenty competitors to win this year’s Cancer Research Excellence in Surgical Trials (CREST) award from the National Institute for Health Research- Cancer (NIHR CRN).